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   Hydroxamic acid， a potent and specific inhibitor of bacterial urease activity， was found to be
effective for the p．r6ventign gf．alkalipization 6f infected urine and bladder stqne formation．
   1．． Among new hydroxamic acid derivatives of hippuric acid， m－methoxyhippurohydroxamic
acid （UCD II） was expected to be mpst effective， because of the strong inhibitory power against urease
．…i・i・y・・d・h・ゆ．・ri・4・y塁6reti・4 i・．・at・ゆ・u・d・g・ad・・量・n・
   2． UCD II prevented the alkalinization of experimentally infected urine in vitro．
   3． UCD II significantly prevented the bladder stone formation as well as alkalinization of urine
in vivb， whcn the compQund was orally administered to the rats with urinary tract infection caused
by Proteus mirabilis．
   4． Clinieal application of UCD II was dependent upon the evaluation of safety of the compound，
























実 験 方 法
実験1．新ヒドロキサム酸誘導体のウレアーゼ活性阻














    化抑制効果
 正常人尿中lc Proteus mirabilis I o6／mlを混入し実験
的感染尿とし，37。C保温で8時間，24時間後のpH
を測定した．UCD IIを2×10－4 M，5×10－4・Mお
























         recovery ％ in urine for 24 hr
竹内・ほか．：ウレアーゼ阻害剤・尿路結石予防（3）

































































































UCD r ： m－methoxy－hippuro 一・
    hydroxamic acid








た．すなわちUCD II 2×10『4 M存在下では8時間
後pH 7．65±0．03，12時間後pH 8．73±O．04， UCD
II 5×10 74 M存在下ではpH 7・43±O・06， pH 8・17±
24           竹内・ほか：ウレア」ゼ阻害剤・尿路結石予防．（3）
























Effect of UCD II on alkalinization of
urine．
Table 2． Effect of UCII） II on b1adder stone．
No． of Urine
rats m lpH uc增D1％Sb㌦職騙㎞
a． Control
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     Fig． 4
5 Day
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 2） UCD II添加により実験的感染尿のアルカリ化
は顕著に抑制された．
 3）Proteus菌汚染亜鉛片を膀胱内に挿入したラッ
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